The QualityStocks Daily Thursday, March 28th, 2019

Today's Top 3 Investment Newsletters

CryptoCurrencyWire (PFSF) +125.00%

OTCtipReporter (CLWT) +105.09%

MarketBeat (TCDA) +57.04%

The QualityStocks Daily Stock List

Northern Minerals & Exploration Ltd. (NMEX)

Club Penny Stocks Network, OTPicks, OTCBB Journal, Orbit Stocks, Northern Miner, SmallCapVoice, Proactive Investors, Penny Stock Tweets, Mining Feeds, MarketWatch, TopPennyStockMovers, First Penny Picks, InvestorsHub, Marketwired, Junior Mining Network, OTC Markets, Wallet Investor, 4-Traders, and Stockhouse reported earlier on Northern Minerals & Exploration Ltd. (NMEX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Northern Minerals & Exploration Ltd. is a natural resource company listed on the OTC Markets. Its focus is on oil and gas exploration & production in Texas, gold & silver exploration in Nevada, and hotel & resort development in Mexico. The Company previously went by the name Punchline Resources Ltd. It changed its corporate name to Northern Minerals & Exploration Ltd. in August of 2013. Northern Minerals & Exploration is based in Salt Lake City, Utah.

In 2017, Northern entered into a Letter of Intent (LOI) with a private Mexican entity to work together and conduct due diligence for participating in projects in Mexico with an initial emphasis on a property in the State of Quintana Roo. This Property is a part of the Riviera Maya. It is near the earlier discovered Ichkabal Mayan ruins. It is positioned on the Caribbean coast of the Yucatan Peninsula. The Company considers the Property to have considerable potential for resort development.

Northern Minerals & Exploration has established a Mexican Subsidiary - Enmex Operaciones for Real Estate Development Projects in Mexico. In addition, the Company created Kathis Energy LLC, as a wholly-owned subsidiary. Kathis is establishing oil and gas operations in west and south Texas.

Furthermore, this month, Northern Minerals & Exploration announced the signing of a Memorandum of Understanding (MOU) with Labrador Capital SAPI De CV on March 8, 2019. This is the initial step toward entering into a Joint Venture (JV) Agreement for pursuing real estate development opportunities in the Puerto Morelos region of the Yucatan Peninsula of Mexico with Labrador.

Labrador has successfully developed real estate projects in Mexico, particularly in Puerto Morelos, considered to be the Mexican Riviera in the State of Quintana Roo. Labrador is a significant shareholder of Northern Minerals & Exploration and its President is Mr. Victor Miranda, who also serves as the Company’s Chief Financial Officer.

Northern Minerals & Exploration Ltd. (NMEX), closed Thursday's trading session at $0.111, up 11.00%, on 166,000 volume with 8 trades. The average volume for the last 3 months is 26,873 and the stock's 52-week low/high is $0.0155/$0.111.

chart

Liberated Syndication, Inc. (LSYN)

The Hot Penny Stocks, Market Exclusive, Stockflare, Penny Stock Hub, Tip Ranks, Trading View, Insider Mole, Promotion Stock Secrets, Dividend Investor, Wallet Investor, InvestorsHub, Stock Invest, Investors Hangout, Stockhouse, and Simply Wall St reported earlier on Liberated Syndication, Inc. (LSYN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Liberated Syndication, Inc. engages in the podcast hosting services business in the U.S. The Company previously went by the name Webmayhem, Inc. It changed its corporate name to Liberated Syndication, Inc. in August of 2016. Liberated Syndication has its corporate office in Pittsburgh, Pennsylvania. The Company lists on the OTC Markets Group’s OTCQB.

Liberated Syndication has its OnPublish – Multiple Destination Publishing. Its services provide independent podcasters tools to create a first-rate podcast and get that podcast into as many platforms as possible. The Company is the largest leading podcast network. It provides podcast hosting services for producers of podcasting content; independent podcasters’ tools to publish content; and also mobile applications (apps) for podcasts.

Liberated Syndication’s publishing platform integrates content delivery to social media and blog platforms through OnPublish, the Company’s Facebook App and HTML5 player. OnPublish incorporates publishing to Facebook, Twitter, WordPress and Blogger right from Liberated Syndication (Libsyn).

Concerning Podcast Hosting Services, hosting is optimized for audio and video podcast distribution. The network is speedy and reliable and unmetered bandwidth and flexible storage space increases over time. Furthermore, the Libsyn custom smartphone app for podcasters involves audiences beyond one’s regular audio or video episodes. Four different kinds of content are accepted by the app (audio, video, PDF and text). All in one place, a user can offer their audience extras, blog posts, transcripts, and more.

The Company also offers advertisement insertion on certain of the producers’ content. Regarding MyLibsyn – Premium Content, it is a comprehensive subscription management service. The MyLibsyn offering includes a custom premium page and mobile apps available across four markets. One’s subscribers sign up and create one username and password. They can access their subscription across all available apps and one’s branded premium page.

Liberated Syndication also has its LibsynPRO – Enterprise Solutions. This is for professional media producers and corporate customers. LibsynPRO features podcast network tools. It is a turn-key podcast network solution. It allows for as many different shows and episodes as needed.

Earlier this month, Liberated Syndication announced Revenue of $22,010,132 for the full year 2018. This represents an increase of 108 percent over full year 2017 Revenue of $10,584,219. This Revenue was propelled by the Revenue generated from the Company's acquisition of Pair Networks and also from 30 percent growth in Libsyn Podcasting (Libsyn4) Revenue.

Mr. Chris Spencer, Liberated Syndication Chief Executive Officer, said, "Management expects podcasts to continue to grow in popularity as they have become an integral part of brand strategy along with websites, blogs and social media outlets. We expect 2019 to be a very good year for Liberated Syndication's podcast hosting business and with the changes we've incorporated at Pair Networks, we anticipate strong growth across all aspects of our business.”

Liberated Syndication, Inc. (LSYN), closed Thursday's trading session at $1.78, down 3.26%, on 6,081 volume with 13 trades. The average volume for the last 3 months is 25,145 and the stock's 52-week low/high is $1.05/$1.89.

chart

BioRestorative Therapies, Inc. (BRTX)

Simply Wall St, Capital Cube, Pink Investing, Proactive Investors, 4-Traders, Market Screener, MarketWatch, InvestorsHub, Barchart, Stockopedia, ProActive Capital, GuruFocus, Investor Ideas, Corporate Information, Streetwise Reports, Zacks, Stockhouse, and Marketbeat reported previously on BioRestorative Therapies, Inc. (BRTX), and we also report on the Company, here at the QualityStocks Daily Newsletter.

BioRestorative Therapies, Inc. is a life sciences company focusing on adult stem cell-based therapies for various personal medical applications. The Company develops products and medical procedures utilizing cell and tissue protocols, primarily involving adult stem cells. OTCQB-listed, BioRestorative Therapies has its corporate, administrative, and laboratory operations in Melville, New York.

The Company’s aim is to become a leader in providing medical procedures using cell and tissue protocols, chiefly involving adult stem cells (non-embryonic), and enabling patients to undergo minimally invasive cellular-based treatments. BioRestorative Therapies is developing a cell-based therapy to target obesity and metabolic disorders utilizing brown adipose (fat) derived stem cells to produce brown adipose tissue (BAT). The intention of BAT is to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans.

Bio Restorative’s lead cell therapy candidate is BRTX 100. This product is formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow. The Company’s products and medical procedures include brtxDISC™ (Disc Implanted Stem Cells), its Disc/Spine Program, and ThermoStem®, its Metabolic Program.

brtxDISC™ is an investigational non-surgical treatment for bulging and herniated lumbar discs. brtxDISC™’s intention is for patients who have failed non-invasive procedures and face the prospect of surgery. ThermoStem® is a treatment using brown fat stem cells. ThermoStem® is under development for metabolic disorders, including diabetes and obesity.

BioRestorative Therapies is also the beneficiary of a patent granted for a licensed curved needle device (CND). The design of it is to deliver cells and/or other therapeutic products or material to a site having damage in need of facilitated repair.

Recently, BioRestorative Therapies announced the creation of a Disc Advisory Committee of its Scientific Advisory Board (SAB). Jason Lipetz, MD, a member of the Company’s SAB headed by Dr. Wayne Marasco, will Chair the newly created Committee. Dr. Lipetz joined the SAB in October of 2018.

In addition to Wayne Olan MD, the Director of BioRestorative’s Disc/Spine Regenerative Program, the SAB added Harvinder Sandhu, MD; Christopher Plastaras, MD; and Gerard A. Malanga, MD.

Wayne Marasco, MD, Ph.D., Chairman of the BioRestorative Therapies Scientific Advisory Board, said, "Dr. Jason Lipetz has recruited a prestigious team of spine experts. This SAB subcommittee will provide outstanding leadership and guidance to BRTX as we move toward initiation of our clinical trial for our lead BRTX-100 autologous stem cell product.”

BioRestorative Therapies, Inc. (BRTX), closed Thursday's trading session at $0.74, down 2.63%, on 13,988 volume with 23 trades. The average volume for the last 3 months is 82,255 and the stock's 52-week low/high is $0.49/$4.00.

chart

Midwest Energy Emissions Corp. (MEEC)

SeriousTraders, MissionIR, NBT Equities Research, Greenbackers, Marketbeat, Wall Street Resources, TopPennyStockMovers, and PennyStocks24 reported earlier on Midwest Energy Emissions Corp. (MEEC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Midwest Energy Emissions Corp. is a developing leader in mercury emissions control technology for the international coal-power industry. It develops and utilizes patented and proprietary technologies to remove mercury from coal-power plant emissions. Midwest Energy Emissions centers on the delivery of mercury capture technologies to power plants and other industrial coal-burning units in North America, Europe, and Asia. OTCQB-listed, the Company has its corporate headquarters in Lewis Center, Ohio.

Midwest Energy Emissions employs patented technology, which has been shown to realize mercury removal levels compliant with the U.S. Environmental Protection Agency's (EPA) Mercury and Air Toxic Standards (MATS) rule, at a substantially lower cost and with less operational impact than methods now used. This is while preserving the ability for customers to recycle and sell fly-ash for beneficial use.

The Company’s proprietary SEA™ (Sorbent Enhancement Additive) technology delivers a flexible, tunable solution. It allows the worldwide coal-power industry to easily comply with new, highly restrictive regulations on mercury air emissions. Midwest Energy Emissions acquired all patent rights for its Sorbent Enhancement Additive (SEA™) mercury emissions control technology from the Energy & Environmental Research Center Foundation (EERCF of Grand Forks, North Dakota).

The SEA™ approach to mercury capture is precisely custom-made for each application to complement a customer’s fuel type and boiler configuration for best results. EERCF is an organization that works to provide inventive solutions to the globe’s energy and environmental challenges.

The Company is adding a new product to its proven, cost-effective mercury capture program. The product will lessen mercury emissions by preventing scrubber re-emission events. The design of the product is purposely for coal-fired power utilities with wet scrubbers to help remove mercury and other metals from the scrubber.

This month, Midwest Energy Emissions announced it secured a three-year, multi-million dollar yearly supply contract extension with a present customer. With this extended supply contract, the Company will continue supplying its proprietary Sorbent Enhancement Additive SEA® technologies.

Last week, Midwest Energy Emissions announced its expansion into a present customer’s fleet to supply its proprietary Sorbent Enhancement Additive SEA® technologies to two additional coal-fired boilers. The expectation is that this expansion will produce multi-million dollars each year in Revenue over the course of three years.

Mr. Richard MacPherson, Midwest Energy Emissions’ President and Chief Executive Officer, said, “This expansion was secured with one of the largest utilities in North America and a long-term customer of ours. Our ability to expand into other boilers for this client is a result of our continued best-in-class performance. We believe that our unique ability to bring boilers into emissions compliance with the most efficient, cost effective system will continue to drive new business to our Company in the coming months and years, both with current and new customers.”

Midwest Energy Emissions Corp. (MEEC), closed Thursday's trading session at $0.275, even for the day, on 17,601 volume with 9 trades. The average volume for the last 3 months is 46,829 and the stock's 52-week low/high is $0.11625/$0.469.

chart

GulfSlope Energy, Inc. (GSPE)

TipRanks, Emerging Growth, MarketWatch, Infront Analytics, Stockhouse, OTC Markets, Simply Wall St, Barchart, InvestorsHub, Morningstar, Equity Clock, and Financial Times reported on GulfSlope Energy, Inc. (GSPE), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

GulfSlope Energy, Inc. is an independent oil and natural gas company centering on exploring offshore U.S. Gulf of Mexico. The Company uses 2.2 million acres of 3D seismic data to identify high quality exploration prospects. Its team has a track record of discovering and developing multi-billion-dollar projects around the world, with more than 300 years of combined experience in the oil and gas exploration industry. GulfSlope Energy is headquartered in Houston, Texas.

The Company’s target is the Shelf Miocene (2.2 MM Acres - 440 Blocks). GulfSlope’s present focus is on pre-drill operations. It has a hybrid operating model with a preference to operate. The Miocene Subsalt Play – La Shelf has large resource potential; is low to moderate risk; has moderate drilling and development costs; has shortened times to initial production, and enhanced economics.

Concerning its Phase 1 Drilling Program, GulfSlope Energy has high-graded five prospects with mean unrisked resource potential of 623 MMboe. It is looking to capitalize on strategic advantages provided by exploration work to identify undervalued producing assets. The Company has greater than 2 billion boe of net conventional recoverable resources. It has 23 lease blocks with 19 drilling prospects ranging from 30-280 MMboe. The average size of the prospects is 120 MMboe.

GulfSlope Energy and Texas South Energy, Inc. (TXSO) have entered into a strategic partnership with Delek Group Ltd., an international independent oil and gas company based in Israel. The Companies and Delek have mutually agreed to pursue oil and natural gas opportunities in the Gulf of Mexico.

In late August 2018, GulfSlope Energy announced drilling results for the GulfSlope Energy OCS-G-35589 #1 well on Vermilion Block 378 (VR 378) known as the Canoe Shallow Prospect. Based on Logging-While-Drilling (LWD) and Isotube analysis of hydrocarbon samples, oil sands were encountered in the northwest center of the block.

The well was drilled to a total of 5,765 feet measured depth (5,700 feet true vertical depth). No problems were encountered while drilling. A complete integration of the well information and seismic data will be performed for further evaluation of the shallow potential of the wellbore and the block, and to define commerciality of these oil plays.

GulfSlope Energy recently announced that on September 13, 2018, it started drilling of its initial subsalt exploration well in the Gulf of Mexico on the Tau Prospect located on Ship Shoal Area, South Addition Blocks 336/351.  The Tau Prospect is being drilled with the high-spec Rowan Ralph Coffman jack-up rig that recently completed drilling operations on GulfSlope’s Canoe Prospect.

Mr. John N. Seitz, Chief Executive Officer of GulfSlope Energy, said, “This is the first well to be drilled in our exciting portfolio of high potential subsalt prospects.  Advancements in both imaging and drilling technologies are what enable this play today.  Reverse Time Migration (RTM) depth imaging and critical noise suppression technologies allowed our geoscientists to establish an improved subsurface image below salt.”

GulfSlope Energy, Inc. (GSPE), closed Thursday's trading session at $0.055, up 2.57%, on 555,535 volume with 37 trades. The average volume for the last 3 months is 1,347,316 and the stock's 52-week low/high is $0.02964/$0.20.

chart

OriginClear, Inc. (OCLN)

Penny Stock Tweets, Trading View, Marketbeat, Barchart, MicroCap Daily, Emerging Growth, Chart Diligence, Dividend Investor, Simply Wall St, Capital Cube, InvestorsHub, The Street, Stockwatch, YCharts, Market Screener, Infront Analytics, MarketWatch, Insider Financial, and Wallet Investor reported previously on OriginClear, Inc. (OCLN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OriginClear, Inc. is a foremost provider of water treatment solutions. Additionally, it is the developer of an inventive water cleanup technology. Via its wholly-owned subsidiaries, OriginClear provides systems and services to treat water in a wide array of industries. These include municipal, pharmaceutical, semiconductors, industrial, and oil & gas.

The Company has its wholly-owned subsidiary, Progressive Water Treatment (PWT) of Dallas, Texas. It also has its new operating division, Modular Water Systems (MWS), launched in late June 2018. OriginClear has its head office in Los Angeles, California. The Company lists on the OTC Markets.

OriginClear invented Electro Water Separation™. This is a leading-edge high-speed water cleanup technology employing multi-stage electrolysis that the Company licenses globally to water treatment equipment manufacturers. OriginClear’s mission is to develop Electro Water Separation™ with Advanced Oxidation™ (EWS:AOx™) and accomplish its full recognition as a worldwide industry standard in treating increasingly complex wastewater treatment challenges.

OriginClear has completed development and testing of AOxPlus™. This is a method to produce hydroxyl radicals in large quantities to treat highly contaminated wastewater.

Electro Water Separation™ (EWS) is a highly scalable, continuous process. It uses electricity in small, programmed doses to gather up oils and suspended solids. Moreover, through Advanced Oxidation or AOx, it removes fine, micron-sized suspended solids, and dissolved contaminants, including ammonia.

OriginClear previously engaged London-based The Coin Lab to assist in developing a blockchain protocol, with industry participation, called WaterChain™. The Coin Lab's task is to develop a blueprint and process for executing on the technology strategy of placing the water industry on a blockchain protocol with a water transactional token, or coin.

In February, OriginClear reported that in January, its Progressive Water Treatment subsidiary almost tripled its rate of bookings, totaling approximately $900,000 in Purchase Orders (POs) for January. The largest win was for a power plant, in competition against five major equipment manufacturers.

Riggs Eckelberry, OriginClear’s Chief Executive Officer, said, “I am ecstatic as well as the rest of the OriginClear team with the early results from Marc Stevens, Mike Jenkins and the entire PWT team. They won that large contract against fierce competition because of diversity, attention to detail, and a successful track record. This increase in bookings is a great start for the new year!”

OriginClear, Inc. (OCLN), closed Thursday's trading session at $0.00105, up 16.67%, on 8,786,929 volume with 49 trades. The average volume for the last 3 months is 21,976,880 and the stock's 52-week low/high is $0.0009/$0.048.

chart

ForeverGreen Worldwide Corporation (FVRG)

Hotstocked, MicroCapDaily, The Street, Seeking Alpha, Penny Stock Hub, Penny Stock Tweets, Uptick Newswire, Infront Analytics, Investor Place, OTC Markets, InvestorsHub, 4-Traders, MarketWatch, Stockopedia, YCharts, Simply Wall St, Wallet Investor, GuruFocus, and Barchart reported earlier on ForeverGreen Worldwide Corporation (FVRG), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

ForeverGreen Worldwide Corporation is an international direct marketing business and provider of health and wellness products. The Company develops, manufactures, and distributes a comprehensive line of all-natural whole foods and products to North America, Australia, Europe, Asia, and South America. ForeverGreen Worldwide is based in Lindon, Utah.

ForeverGreen’s products include its global Xpress offering Prodigy-5™, featuring the exclusive TransArmor™ Nutrient Technology. Moreover, its products include PowerStrips™, SolarStrips™, with industry exclusive marine phytoplankton, and BeautyStrips™.

Prodigy-5 is an all-in-one nutritional shot. It features the patent-pending and exclusive TransArmor™ Nutrient Technology for increased absorption. Prodigy-5 provides vitamins, minerals, antioxidants and energy, all in one. The TransAmor™ Nutrient Technology is patent pending. TransAmor™ Nutrient Technology allows the nutrients in formulated products to be significantly better absorbed by the body.

Additionally, the Company has its KetonX product. KetonX is a drink product that allows the body to begin converting into a state of nutritional ketosis within a matter of hours. It features a patented blend of ingredients.

ForeverGreen Worldwide also offers the North American market its weight-management line Ketopia™, as well as additional weight management products. The Company also offers its Pulse-8™ powered L-arginine formula for cardiovascular health. Also, ForeverGreen has its new wearable technology called CareWear™.

ForeverGreen Worldwide is formulating a line of products, specifically using CBD for human wellness. It has previously incorporated CBD in past products. The Company believes the new products will initially be available in the European Markets.

In February, ForeverGreen Worldwide announced it is preparing for its first product launch and expansion into the CBD market.

Mr. Joe Jensen, the Company’s Executive Officer, said, "We are particularly eager to expand our company products into the CBD industry. This is such a rapidly, growing market right now and we anticipate these CBD products are going to drive sales worldwide. The buzz for CBD hemp oil has been steadily increasing and goes along with our overall goal, to promote health and wellness. Capturing a small part of this booming industry is going to bring endless opportunities for ForeverGreen."

Beginning late Q1, five new products featuring CBD oil are to be phased in and completed over the course of this year. ForeverGreen continues its emphasis on the CBD industry and ketogenic products.

ForeverGreen Worldwide Corporation (FVRG), closed Thursday's trading session at $0.112, up 1.82%, on 20,322 volume with 12 trades. The average volume for the last 3 months is 57,154 and the stock's 52-week low/high is $0.0235/$0.3899.

chart

Surna, Inc. (SRNA)

Hot Stock Profits, Ascending Stocks, OTC Stock Review, Promotion Stock Secrets, Wall Street Mover, TopPennyStockMovers, PricelessPennyStocks, MarketWatch, Stockhouse, InvestorsHub, Market Wire Stocks, Best Medical Marijuana Stocks, Value Penny Stocks, Cannabis Financial Network News, SmallCapVoice, Marketbeat, CFN Media Group, PennyStockRumors, DSR News, Greenbackers, PHUB News, and Actual Gains reported earlier on Surna, Inc. (SRNA), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Surna, Inc. develops, acquires, produces, and sells equipment for the legal marijuana industry. The Company develops innovative technologies and products to monitor, control, and address the energy and resource intensive nature of indoor cannabis cultivation. Its corporate mission is to acquire intellectual property (IP) and scalable operating companies in the nascent, legal marijuana industry with a concentration on disruptive technology, equipment, and related support services. A technology business and OTCQB-listed, Surna is headquartered in Boulder, Colorado.

The Company’s objective is to dominate the infrastructure, growing, and support side of the worldwide cannabis industry. The foundation of Surna’s present revenue stream is on its chief product offerings - supplying industrial technology and products to commercial indoor cannabis grow facilities. The Company engineers, manufactures, and distributes state-of-the art equipment and systems for Controlled Environment Agriculture (CEA).

Currently, Surna’s specialty is commercial indoor cannabis cultivation. Its business model excludes the production or sale of marijuana. By way of its wholly-owned subsidiary, Hydro Innovations, the Company provides a comprehensive line of commercial and small business indoor agriculture equipment.

It has its signature water-cooled climate control platform. Surna’s plan is to integrate this and other proprietary technology into a new, commercial-grade power-generating and environmental control system product. This system is undergoing design to provide a near zero waste energy alternative for the cannabis industry.

Surna has its new business model and strategy. The Company will work to decrease its reliance on new build facility projects that generate inconsistent revenue and cash flow. It will also establish revenue from "lifecycle" operational and facility management offerings and operate with a more disciplined expense, cash and working capital management. Furthermore, Surna will work to become financially self-sustaining through attempting to attain cash flow breakeven and operating profit and will raise capital for strategic initiatives when the return on investment (ROI) is quantifiable and justified.

Late last year, Surna decided to focus its next major product initiative in the sensors, controls and automation (SCA) market. It has entered this business to satisfy its customers' needs that the Company did not earlier address and that historically was provided by third-party controls contractors. Surna will be one of the few mechanical systems providers in the market to offer a branded, proprietary HVAC equipment package and a branded SCA product line. 

Surna, Inc. (SRNA), closed Thursday's trading session at $0.065, even for the day, on 378,066 volume with 45 trades. The average volume for the last 3 months is 378,632 and the stock's 52-week low/high is $0.050145/$0.289.

chart

Artemis Therapeutics, Inc. (ATMS)

NetworkNewsWire, Stock Digest, Last10k, GuruFocus, MarketWatch, Zacks, Wallmine, OTC Markets, Penny Stock Tweets, 4-Traders, YCharts, Stockhouse, InvestorsHub, NASDAQ.com, Simply Wall St, Financial Content, Morningstar, and Barchart reported previously on Artemis Therapeutics, Inc. (ATMS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Artemis Therapeutics, Inc. centers on the development of new therapies for the treatment and prevention of severe and life-threatening infectious diseases. The Company’s lead product candidate is Artemisone. This is a unique, synthetic artemisinin derivative with potent anti-viral and anti-parasitic properties.  A clinical-stage biopharmaceutical company and OTCQB listed, Artemis Therapeutics is headquartered in New York, New York.
 
Artemisone is a best-in-class artemisinin. It has been studied in a Phase 2 clinical trial for the treatment of malaria (p. falciparum). The Company has licensed pre-clinical data from Hadasit Medical Research Services and Development Ltd. in HCMV and clinical data from Hong Kong University of Science and Technology R and D Corporation Limited (RDC) in the treatment of Malaria.

Artemisinin and its derivatives, including artesunate, artemether, arteeter and dihydro-atemisinin (DHA), have for numerous years been the foundation of treatment of uncomplicated p. falciparum malaria. Phase II clinical data has shown Artemisone to be an effective treatment for p. falciparum malaria infection when dosed over a 2-day or 3-day course, alike to or shorter than other available malaria treatments.

At present, Artemisone is undergoing in vitro evaluation for its activity against human cytomegalovirus (CMV). This includes transplant CMV and congenital CMV. Artemis announced in June of 2018 that new data on its lead product candidate Artemisone shows it is a potent inhibitor of human cytomegalovirus (HCMV) replication in preclinical assays. The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Artemisone for the treatment of malaria.

Artemisone in a preclinical setting is a potent inhibitor of human cytomegalovirus (HCMV) replication and the transmissible stages of malaria. Human cytomegalovirus (CMV) is a common virus related to the viruses that cause chickenpox, herpes simplex, as well as mononucleosis. CMV is transmitted via bodily fluids. Artemis Therapeutics’ lead product candidate, Artemisone, is undergoing development as a best-in-class treatment for malaria and first-in-class treatment for CMV.

Artemis Therapeutics, Inc. (ATMS), closed Thursday's trading session at $0.2601, down 0.02%, on 3,545 volume with 1 trade. The average volume for the last 3 months is 303 and the stock's 52-week low/high is $0.26/$1.15.

chart

Intrusion, Inc. (INTZ)

Zacks, Investor Place, Wallstreet Online, Morningstar, Market Screener, InvestorsHub, InvestingOnline, Marketbeat, 4-Traders, Wallet Investor, Barchart, The Street, Stockopedia, Capital Cube, OTC Markets, and MarketWatch reported on Intrusion, Inc. (INTZ), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Intrusion, Inc. is an international provider of entity identification, high speed data mining, cybercrime, and advanced persistent threat detection products. The Company’s product families include TraceCop™ for identity discovery and disclosure, and Savant™ for network data mining and advanced persistent threat detection. OTCQB-listed, Intrusion is headquartered in Richardson, Texas.

The Company’s products help protect critical information assets. These products do so through quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private, and regulated information for government and enterprise networks.

Intrusion’s TraceCop is a set of Internet monitoring and tracking products. They provide exceptional capabilities for the identification of malicious and illegal activities based on historical and current Internet usage data. TraceCop helps analysts and investigators significantly reduce the time and complexity for discovering identities, ownership, and contact information for computer devices on the Internet.

At the heart of TraceCop is a premier data collection process. The process continuously collects, processes and stores wide-ranging amounts of historical Internet usage and traffic data into the TraceCop Databases.

Intrusion’s Savant is a transparent network data capture and analysis solution. Savant brings science into corporate decision making. It provides real-time access and insight into an enterprise’s own indisputable and quantifiable network data for more effective, unbiased decision making. Savant is a purpose-built appliance. It performs an innovative, real-time, transparent data capture and analysis of all content across a company’s network. This includes the “who, what, when and where” of the data from any application.

Intrusion also has its Secure Taps™. It offers a collection of secure network taps. These enable easy, quick, and strong deployment of any of the Company’s network security appliances. Using a Secure Tap is a first-rate method for deploying network appliances.

Recently, Intrusion announced financial results for the three and six months ended June 30, 2018. Net Income was $474,000 in Q2 2018, versus a Net Loss of $438,000 in Q2 2017 and Net Income of $346,000 in Q1 2018. Revenue for Q2 2018 was $2.4 million versus $1.5 million in Q2 2017 and $2.3 million for Q1 2018.

Intrusion, Inc. (INTZ), closed Thursday's trading session at $4.18, up 0.72%, on 3,839 volume with 17 trades. The average volume for the last 3 months is 15,275 and the stock's 52-week low/high is $0.819/$4.45.

chart

Liberty Leaf Holdings Ltd. (LIBFF)

NetworkNewsWire, Penny Stock Hub, Stocks To Buy Now, TipRanks, Stockwatch, Investorx, Barchart, Capital Cube, Stockhouse, The Seed Investor, Cannabis News Wire, MarketWatch, InvestorsHub, and Investors Hangout reported on Liberty Leaf Holdings Ltd. (LIBFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Liberty Leaf Holdings Ltd.’s focus is to build and support a diverse portfolio of cannabis-sector businesses. This includes cultivation, cannabidiol (CBD)/tetrahydrocannabinol (THC) products, biotechnology research and supply-chain products within this fast-developing sector. Liberty Leaf Holdings is based in Vancouver, British Columbia.

The Company works to acquire partnership interests in up-and-coming and established companies in the medicinal and recreational cannabis arena. Liberty Leaf operates in Canada and is looking to enter the varied legal cannabis markets in North America.

Liberty Leaf Holdings announced in December of 2017 that it acquired a majority interest in Just Kush Enterprises. Just Kush owns complete control over a current Medical Marijuana Access Regulations (MMAR)-licensed production facility. This acquisition complements Liberty Leaf Holdings’ purchase in 2016 of North Road Ventures. North Road concentrates on the value-added aspect of the cannabis product processing business, sales, and complementary distribution. North Road Ventures is a developing distributor of cultivated and manufactured cannabis products to licensed legal retailers. North Road is expanding into the recreational market.

Mr. Will Rascan, Liberty Leaf Holdings’ President and Chief Executive Officer, announced in March 2018 the signing of an agreement between North Road Ventures, a wholly-owned subsidiary of Liberty Leaf, and Cannabis Compliance, Inc. (CCI). Under the agreement, CCI will be responsible for guiding the Good Manufacturing Practice (GMP)-compliant processing/production of North Road's cannabis-containing and other finished products.

Recently, PUF Ventures, Inc., an advanced Access to Cannabis for Medical Purposes Regulations (ACMPR) license applicant, and Liberty Leaf Holdings announced the execution of a Memorandum of Understanding (MOU) that outlines the basis where the Parties will undertake the creation of a joint venture (JV) partnership to develop a medical cannabis project for the cultivation and sale of medical cannabis in Greece. At present, the JV company is in talks with potential local partners with suitable resources and expertise to participate in the development of a large-scale, medical cannabis commercial cultivation operation.

Liberty Leaf Holdings also recently announced that work at Just Kush is now complete on the buildout of its "Phase I" cultivation production facility. Therefore, on October 29-30, 2018, Cannabis Compliance (CCI) will conduct its site visit walk through of the Just Kush facility and gather video footage as part of the Affirmation of Readiness (AOR) submission to Health Canada.

Mr. Will Rascan said, "I am very excited with the final result of the completed buildout. Coupled with our innovative technologies, what this means is that Just Kush can now officially notify Health Canada that it's ready for cannabis licensing."

Liberty Leaf Holdings Ltd. (LIBFF), closed Thursday's trading session at $0.1216, up 10.65%, on 5,027 volume with 7 trades. The average volume for the last 3 months is 34,122 and the stock's 52-week low/high is $0.057/$0.35.

chart

Kaya Holdings, Inc. (KAYS)

Stockflare, TipRanks, Daily Marijuana Observer, Zacks, OTC Markets, Barchart, Equity Clock, Stockhouse, The Street, and Microcap Daily reported on Kaya Holdings, Inc. (KAYS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Kaya Holdings, Inc., by way of subsidiaries, produces, distributes and sells legal premium medical and recreational cannabis products. These include flower, concentrates and oils, and cannabis-infused foods. Kaya Holdings has its corporate office in Fort Lauderdale, Florida. The Company lists on the OTC Markets Group’s OTCQB.

In January 2014, Kaya Holdings incorporated a subsidiary, Marijuana Holdings Americas, Inc., a Florida corporation (MJAI). Through entities controlled by MJAI, Kaya concentrates on opportunities in the legal recreational and medical marijuana sectors in the U.S.

Kaya Holdings operates four Kaya Shack™ OLCC (Oregon Liquor Control Commission) licensed marijuana retail stores to serve the legal medical and recreational marijuana market in the State of Oregon. The Company developed the Kaya Shack™ brand for its retail operations. In April of 2015, Kaya Holdings started its own medical marijuana grow operations for the cultivation and harvesting of legal marijuana.

The Company has completed the processes required to launch its own home delivery service in Portland and Salem, Oregon. It expects to operate four cars at first, with more cars to be added as demand requires and as Kaya expands into other cities in Oregon.

Kaya Holdings had Revenues of $291,133 for the three months ended June 30, 2018, versus Revenues of $199,790 for the three months ended March 31, 2017, and Revenues of $546,498 for the six months ended June 30, 2018, versus revenues of $344,651 for the six months ended March 31, 2017. This represents a 45 percent year-over-year increase in Revenues for Q2 2018 versus 2017, and an almost 60 percent year-over-year increase in Revenues for the first six months of 2018 versus the same period of 2017.

Recently Kaya Holdings announced that it entered into a preliminary agreement to purchase a Eugene, Oregon Marijuana Grow and Manufacturing Facility in a $1.55 million deal. This deal includes an asset acquisition agreement to purchase a 12,000 square foot indoor marijuana grow and manufacturing facility with a present production capability of 800 pounds of high quality medical and recreational cannabis per year.

Kaya Holdings, Inc. (KAYS), closed Thursday's trading session at $0.089, down 1.11%, on 138,641 volume with 24 trades. The average volume for the last 3 months is 202,081 and the stock's 52-week low/high is $0.078/$0.173.

chart

Nickel Creek Platinum Corp. (NCPCF)

InvestorsHub, InvestorX, The Frugal Forager, Northern Miner, Stockhouse, Metals News, Business Insider, OTC Markets, Investors Hangout, Wallmine, and Portfolio Sharing reported earlier on Nickel Creek Platinum Corp. (NCPCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nickel Creek Platinum Corp. is a mining exploration and development company headquartered in Toronto, Ontario. Its focus is on advancing its 100 percent-owned Nickel Shäw Project with the aim of creating Canada's next world-class nickel sulphide mine. The Company previously went by the name Wellgreen Platinum Ltd. It changed its corporate name to Nickel Creek Platinum Corp. in January of this year. Nickel Creek Platinum lists on the OTC Markets Group’s OTCQX.

The 100 percent-owned Nickel Shäw project is positioned in the southwest of Canada’s Yukon Territory, around 317 km northwest of the capital, Whitehorse. The Project has excellent access to infrastructure, located three hours west of Whitehorse via the paved Alaska Highway, which further provides year-round access to deep-sea shipping ports in southern Alaska.

Nickel Shäw is host to more than 2 billion pounds of nickel, 1 billion pounds of copper, 6 million ounces of platinum group metals (PGM's) and 120 million pounds of cobalt in the Measured and Indicated categories. The Nickel Shäw Property lies within the Kluane First Nation core area as defined by their treaty with Canada and the Yukon Government.

Nickel Creek Platinum reported this past July the final results of its Phase II Metallurgical Program on the Nickel Shäw Project. The Phase II Metallurgical Program succeeded in its primary objective of separating bulk CuNi concentrate into separate saleable nickel and copper concentrates. This represents the most in-depth and comprehensive metallurgical undertaking completed so far at the Project.

Recently, Nickel Creek Platinum announced an update on the status of its Nickel Shäw Project. Following the conclusion of the Company’s Phase II Metallurgical Program, it embarked on more work toward completing a Preliminary Economic Assessment (PEA).  During the course of the Phase II Metallurgical Program, it reported that it identified a strong correlation between nickel recovery and total sulphide content.

Particularly, it was determined that the presence of sulphides (sulphur in pyrrhotite) was an important marker of nickel recovery. This means that the areas of higher sulphur yielded higher recoveries, and areas of lower sulphur yielded lower recoveries, irrespective of nickel head grade, which remains relatively consistent throughout the deposit.

Nickel Creek Platinum Corp. (NCPCF), closed Thursday's trading session at $0.0454, up 6.07%, on 130,379 volume with 14 trades. The average volume for the last 3 months is 142,891 and the stock's 52-week low/high is $0.043/$0.227.

chart

AIT Therapeutics, Inc. (AITB)

NetworkNewsWire, Zacks, Wolfstreet, MarketWatch, Emerging Growth, Morningstar, Stockhouse, Stockopedia, TradingView, Barchart, Insider Financial, Canadian Insider, Street Insider, last10k, Wallet Investor, GuruFocus, Real Investment Advice, 4-Traders, TipRanks, and InvestorPlace reported on AIT Therapeutics, Inc. (AITB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AIT Therapeutics, Inc. is a clinical-stage medical device and biopharmaceutical company based in Garden City, New York. The Company focuses on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions. These include serious lung infections and pulmonary hypertension. AIT Therapeutics also has an office in Ness Ziona, Israel. The Company lists on the OTC Markets Group’s OTCQB.

AIT’s technology originated at the University of British Columbia, Department of Infectious Disease in Vancouver. In 2011, Advanced Inhalation Therapies (AIT) was established and the Company developed a proprietary technology to safely deliver Nitric Oxide (NO) gas to patients with bronchiolitis and cystic fibrosis. In 2017, AIT Therapeutics became a publicly traded company.

At present, AIT Therapeutics is applying its therapeutic expertise to treat lower respiratory tract infections not effectively addressed with present standards of care, and also pulmonary hypertension, in different settings. The Company is now advancing its pioneering NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and severe lung infections including nontuberculous mycobacteria (NTM).

AIT Therapeutics’ propriety generator and delivery system generates NO from room air. This eliminates the need for costly and cumbersome cylinders. The Company’s system allows for numerous significant advantages over approved NO cylinder based systems now used in hospitals worldwide and may allow for use in the home setting.

AIT has conducted greater than 2,100 treatments in more than 85 patients across 7 studies at “high” NO concentrations. There are no serious adverse events related to NO therapy. NO is recognized as an important molecule involved in numerous physiological and pathological processes. NO is naturally produced by the body’s immune system to provide a first line of defense against invading pathogens. NO is a powerful molecule and has a short half-life of a few seconds in the blood. This enables it to be cleared quickly from the body.

Recently, AIT Therapeutics announced that it started commercial development for its ventilator compatible NO generator and delivery system with Sparton Corporation. AIT and Sparton expect to complete the process in about 6 months. AIT will make a 510(k) submission to the Food and Drug Administration (FDA) soon thereafter. Sparton is a leader in the design and manufacture of highly complex electromechanical devices.

AIT Therapeutics also recently announced a poster presentation on inhaled NO at the North American Cystic Fibrosis Conference, taking place October 18-20, 2018 in Denver, Colorado. This poster will contain results of high-dose nitric oxide as an antibacterial agent in the treatment of Mycobacterium abscessus complex (MABSC). MABSC is one of the most antibiotic-resistant pathogens and difficult to treat species of nontuberculous mycobacteria (NTM). Presently, there are no approved treatments for MABSC.

AIT Therapeutics, Inc. (AITB), closed Thursday's trading session at $4.80, up 1.05%, on 69,877 volume with 138 trades. The average volume for the last 3 months is 11,744 and the stock's 52-week low/high is $2.23/$5.50.

chart

The QualityStocks Company Corner

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning announced that Hamilton City Council approved its settlement offer and will allow TGOD to operate its Ancaster, Ontario cannabis greenhouse upon the Local Planning Appeal Tribunal’s confirmation of the settlement at a meeting scheduled for April 25, 2019. To view the full press release, visit: http://nnw.fm/3e0dO. Also today, the company was announced as being part of the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series.  Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET, with the first live webcast at 9:30 AM ET, on Thursday, April 4th. REGISTER NOW AT: https://tinyurl.com/April2019VIC. Additionally, the company was highlighted in an article examining how European CEO, a leading subscription-based print and online publication, delivered to executives in 28 countries throughout Europe, has been tracking the growing CBD market in Europe. A recent article of  theirs was titled: “High demand: CBD-based products gain popularity in European markets – As legalization continues to bring cannabis into the mainstream, high-end products containing its CBD compound are becoming increasingly popular across Europe.”

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.55, up 2.31%, on 1,161,417 volume with 1,451 trades. The average volume for the last 3 months is 1,411,263 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities. To view the full publication, titled “Advanced Medical Technologies Provides Unprecedented Targeting in Cancer Therapy,” visit: http://nnw.fm/l3DkV.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed the day's trading session at $1.6583, up 2.05%, on 128,930 volume with 457 trades. The average volume for the last 3 months is 47,886 and the stock's 52-week low/high is $0.95/$19.45.

Recent News

chart

Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

Smart energy efficiency platform developer Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is building a presence in the U.S. market with a burst of activity that befits its core fundamentals for directing energy where it can be best used to greater gain. Additionally, Kontrol, a leader in the energy efficiency sector, was recently featured in an article authored by Equity Insight titled ‘Can Shares of Kontrol Energy Increase over 200% in 2019?’. To view the full press release, visit: http://nnw.fm/nHmY1.

Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.79, up 6.76%, on 44,993 volume with 29 trades. The average volume for the last 3 months is 34,344 and the stock's 52-week low/high is $0.46/$0.99.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood, Inc. (OTCQB: NGTF), the innovative company solving America’s $50 billion-dollar nighttime snacking problem, has announced today that it has secured retail distribution in the states of North Carolina and South Carolina.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed the day's trading session at $0.665, up 3.10%, on 183,874 volume with 94 trades. The average volume for the last 3 months is 534,319 and the stock's 52-week low/high is $0.16/$0.92.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

British Columbia-based company Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ), with reported visual confirmation of considerable spodumene mineralization within first-phase core drilling samples, expects to greatly expand the historical published resource (1.2 million tons grading 1.51 percent Li2O) for its southern Manitoba lithium mining project. To view the full article, visit: http://nnw.fm/BTv7L.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.189, up 0.05%, on 43,324 volume with 12 trades. The average volume for the last 3 months is 64,382 and the stock's 52-week low/high is $0.1155/$0.5122.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTCQB:SING) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities http://nnw.fm/5Ck1Z.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.01686, up 8.49%, on 4,451,309 volume with 183 trades. The average volume for the last 3 months is 5,843,831 and the stock's 52-week low/high is $0.0106/$0.068.

Recent News

chart

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) this morning announced its entry into a promissory note with Cannaki Beverage Inc., a Las Vegas, Nevada-based manufacturer of natural and organic functional beverages with core products that include still and carbonated beverages and Nano CBD infused flavored waters. To view the full press release, visit: http://nnw.fm/3kqUX.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.1518, even for the cold, on 302 volume. The average volume for the last 3 months is 421 and the stock's 52-week low/high is $0.10/$0.505.

Recent News

chart

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

The QualityStocks Daily Newsletter would like to spotlight Therma Bright, Inc. (OTC: THRBF).

Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company is pleased to announce, further to the press releases on October 11th and December 17th, 2018, that the Company is in the final stages of in vitro testing and awaits the results of the TherOZap™ technology against the Zika virus. Testing is being conducted through a top research laboratory in Canada. The Company expects to report further information as it becomes available.

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.

Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.

The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.

Products

The company currently has two products on the market and another in the research and development phase:

InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.

InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.

The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.

Cannabis

Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.

Market Opportunity

A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.

Management

Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.

**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

Therma Bright, Inc. (OTC: THRBF), closed the day's trading session at $0.0254, even for the day, on 1,000 volume. The average volume for the last 3 months is 2,238 and the stock's 52-week low/high is $0.0099/$0.0289.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, expects to see continued growth in 2019 as a result of its powerhouse subsidiaries, which are increasing their industry presence through retail expansion and land acquisition. NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://nnw.fm/YGYI.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $5.82, off by 1.19%, on 115,982 volume with 972 trades. The average volume for the last 3 months is 216,580 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) (GGB or the Company) is pleased to announce the opening of  its newest Seventh Sense Botanical Therapy CBD shop today at Mayfair Mall in Greater Milwaukee, a Brookfield Properties center. This new location represents the sixth Seventh Sense Shop to open in the United States.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.42, off by 1.44%, on 87,143 volume with 226 trades. The average volume for the last 3 months is 211,823 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market. As CBD moves into the mainstream, opportunities are likely to grow exponentially for a variety of companies, including plant-based health and wellness product developer Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile).

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.5241, off by 1.11%, on 9,483 volume with 11 trades. The average volume for the last 3 months is 14,950 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

British Columbia-based fully-integrated cannabis company Choom Holdings (CSE: CHOO) (OTCQB: CHOOF) this morning announced its entry into a memorandum of understanding ("MOU") with Better Choice Company, Inc. for exclusive Canadian distribution rights to its cannabidiol ("CBD") Bona Vida brand of products targeted for animal health and wellness once approved for sale in Canada. To view the full press release, visit: http://nnw.fm/Wu5bK. Also today, the company was highlighted in an article looking at how, as the global pet care market continues it seemingly never-ending rise, year after year… all things point to the fact that CBD infused products will be among the winners in the race to revenues.

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.50345, off by 2.24%, on 562,776 volume with 232 trades. The average volume for the last 3 months is 558,106 and the stock's 52-week low/high is $0.285/$1.129.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (MCOA) an innovative hemp and cannabis corporation, is pleased to announce that the Company’s wholly owned subsidiary, hempSMART, Ltd., has successfully launched sales of the hempSMART™ product line in the United Kingdom during the London event on March 23, 2019. Also today, the company was highlighted in an aerticle talking about how, after passing a medical marijuana law in December 2018, Utah has now engaged high gear in moving towards implementing the program. The state is currently looking for a software provider who will design a two-part system that will, in effect, run the entire medical cannabis program. Additionally, the company was highlighted in an article examining how European CEO, a leading subscription-based print and online publication, delivered to executives in 28 countries throughout Europe, has been tracking the growing CBD market in Europe. A recent article of  theirs was titled: “High demand: CBD-based products gain popularity in European markets – As legalization continues to bring cannabis into the mainstream, high-end products containing its CBD compound are becoming increasingly popular across Europe.”

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0154, off by 0.84%, on 13,397,098 volume with 532 trades. The average volume for the last 3 months is 12,376,454 and the stock's 52-week low/high is $0.01025/$0.0498.

Recent News

chart

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

Global Payout (OTC: GOHE) along with its wholly-owned subsidiary MTrac Tech Corporation today announced Mtrac’s expansion into two new markets – Oregon and Hawaii. To view the full press release, visit: http://nnw.fm/YS0Np.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed the day's trading session at $0.0043, off by 14.00%, on 19,054,239 volume with 174 trades. The average volume for the last 3 months is 6,041,784 and the stock's 52-week low/high is $0.004/$0.0315.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.